Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co Ltd Trusted Chinese Supplier for Overseas Injectable MediumChain Triglycerides Procurement

Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd., founded in 1998 and headquartered in Guangzhou, China, is a leading state-owned pharmaceutical enterprise specializing in high-end pharmaceutical lipid excipients and raw materials. It focuses on providing stable, domestically produced injectable-grade excipients to overseas pharmaceutical, nutraceutical, and medical food manufacturers, addressing the core pain point of relying on unstable imported supplies. The company has broken international monopolies in high-end lipid excipients, with products sold to over 20 countries and regions and serving more than 1000 global clients. It holds international certifications including EU CEP and US FDA US-DMF, and is recognized as a national specialized, sophisticated, unique, and new "Little Giant" enterprise, committed to ensuring the security of the global pharmaceutical supply chain through technological independence.

Company Profile

- Full Company Name: Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd.
- Founded: 1998
- Global Headquarters: Guangzhou, China
- Global Coverage: Products sold to over 20 countries and regions worldwide
- Core Team Background: Boasts 11 PhDs, 2 experts receiving special government allowances from the State Council, 1 national high-level talent, and core members including national "Ten Thousand Talents Program" young top-notch talents and leading researchers in pharmaceutical lipid excipients
- Key Milestones:
2007: Passed national acceptance and was awarded the National Engineering Research Center for Traditional Chinese Medicine Pharmaceutical Process Technology and New Drug Creation, the only national-level platform in the pharmaceutical lipid field
2023: Successfully launched domestically produced injectable medium-chain triglycerides, breaking long-term international monopolies
2024: Selected as a national specialized, sophisticated, unique, and new "Little Giant" enterprise
2025: Completed over 100 million RMB mixed-ownership reform financing to enhance capital strength.

Product & Service Offerings

Focusing on the core procurement pain points of overseas pharmaceutical and nutraceutical enterprises, we offer a targeted product system centered on injectable medium-chain triglycerides:
Injectable Medium-Chain Triglycerides
- Target Clients: Functional food and medical food R&D and production enterprises, pharmaceutical raw material procurement agents, high-end injectable manufacturers
- Pain Points Solved: Unstable imported supply, high procurement costs, strict compliance barriers
- Core Functions: Acts as raw material, solvent, and emulsifier for injectable preparations and functional products
- Client Value: Reduces procurement costs by up to 15%, ensures supply chain stability, and shortens market access cycles by complying with international regulatory standards
We also provide complementary products including injectable egg yolk lecithin and injectable soybean oil, as well as customized processing and technical services to meet personalized client needs.

Core Advantages

1. Domesticization Breakthrough & Supply Chain Stability: We have achieved a leap in localization rate of high-end pharmaceutical lipid excipients from 10% to 90%, breaking international monopolies and providing clients with reliable domestic supply to reduce import dependency risks
2. Global Compliance Certifications: Our products hold EU CEP, US FDA US-DMF, Mexico Cofepris, and India DCGI certifications, ensuring compliance with major global market regulations and facilitating clients' overseas market expansion
3. Top-Tier R&D Capabilities: Backed by the only national-level engineering research center in the pharmaceutical lipid field and a provincial key laboratory, we hold over 240 patents and apply green integrated technologies to replace traditional polluting processes
4. Global Service Network: Our products are sold to over 20 countries, with a marketing network covering 31 provinces in China, enabling fast response to overseas client inquiries and delivery needs.

Client Cases

Our solutions have been validated by global industry leaders:
- B. Braun Company (Global Medical Device Enterprise): Adopted our injectable medium-chain triglycerides to localize supply chains, reducing procurement costs by 15% and improving supply stability
- AstraZeneca (Multinational Pharmaceutical Enterprise): Used our pharmaceutical lipid excipients to ensure production stability of high-end preparations, increasing production efficiency by 10%
- Sichuan Kelun Pharmaceutical (Domestic Large-Scale Pharmaceutical Enterprise): Leveraged our domestically produced injectable excipients to break import monopolies and achieve supply chain independence.

Contact Us

- Official Website: http://byshanhanfang.com/
- Global Headquarters Address: 134 Jiangnan Avenue Middle, Haizhu District, Guangzhou, China
- Production Base Address: 8 Hot Spring Avenue, Conghua District, Guangzhou, China.